Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Sairah Ahmed, MD, Heather Lin, PhD, Veera Baladandayuthapani, PhD, Mubeen A Khan, Gary Lu, MD, Gabriela Rondon, MD, Sofia Qureshi, Yvonne T Dinh, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Chitra M Hosing, MD, Uday Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 333.

https://doi.org/10.1182/blood.V118.21.333.333

Published: 2011

Journal Articles

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Shatha Farhan, MD, Heather Lin, PhD, Veerabhadran Baladandayuthapani, Nina Shah, MD, Qaiser Bashir, MD, Chitra M Hosing, MD, Uday Popat, M.D., Simrit Parmar, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4119.

https://doi.org/10.1182/blood.V118.21.4119.4119

Published: 2011

Journal Articles

Increased Bone Marrow Plasma Cell Infiltration Pre-Transplant Is Associated with Worse Outcomes in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma,

Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Uday R Popat, MD, Yago Nieto, MD, PhD, Roy Jones, MD, PhD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4135.

https://doi.org/10.1182/blood.V118.21.4135.4135

Published: 2011

Journal Articles

Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics

Sairah Ahmed, MD, Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Tiffany Avery, MD, MPH, Robert Z. Orlowski, MD, PhD, Richard Champlin, MD, Muzaffar Qazilbash, MD, Nina Shah, MD

Blood (2011) 118 (21): 2017.

https://doi.org/10.1182/blood.V118.21.2017.2017

Published: 2011

Journal Articles

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Syed Kazmi, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Chitra M Hosing, MD, Uday Popat, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4156.

https://doi.org/10.1182/blood.V118.21.4156.4156

Published: 2011

Journal Articles

Outcome of IgD Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

Sofia Qureshi, MD, Manish Sharma, MD, Chitra Hosing, MD, Floralyn L Mendoza, MD, Jatin Shah, MD, Amin Alousi, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Issa F Khouri, MD, Uday Popat, MD, Marcos de Lima, MD, Richard E Champlin, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD

Blood (2009) 114 (22): 4354.

https://doi.org/10.1182/blood.V114.22.4354.4354

Published: 2009

Journal Articles

Durable Remission with Salvage Autotransplants in Patients with Multiple Myeloma.

Nina Shah, MD, Khawaja Fraz Ahmed, Sofia Qureshi, Jatin Shah, MD, Robert Z Orlowski, M.D., Ph.D., Donna M Weber, M.D., Chitra Hosing, Uday Popat, MD, Amin Alousi, MD, Richard E Champlin, MD, Sergio Giralt, M.D., Muzaffar Qazilbash, MD

Blood (2009) 114 (22): 1227.

https://doi.org/10.1182/blood.V114.22.1227.1227

Published: 2009

NARROW

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Increased Bone Marrow Plasma Cell Infiltration Pre-Transplant Is Associated with Worse Outcomes in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma,

Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Outcome of IgD Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

Durable Remission with Salvage Autotransplants in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Increased Bone Marrow Plasma Cell Infiltration Pre-Transplant Is Associated with Worse Outcomes in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma,

Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Outcome of IgD Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

Durable Remission with Salvage Autotransplants in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only